Zhifeng Wei Selected Research

Inflammation (Inflammations)

1/2023	Nicotinamide adenine dinucleotide metabolism: driving or counterbalancing inflammatory bowel disease?
1/2020	Pharmacological activation of ERβ by arctigenin maintains the integrity of intestinal epithelial barrier in inflammatory bowel diseases.
1/2018	Tetrandrine attenuates the bone erosion in collagen-induced arthritis rats by inhibiting osteoclastogenesis via spleen tyrosine kinase.
12/2013	Scopoletin suppresses IL-6 production from fibroblast-like synoviocytes of adjuvant arthritis rats induced by IL-1β stimulation.
12/2012	Inhibition of monosodium urate crystal-induced inflammation by scopoletin and underlying mechanisms.
8/2012	Norisoboldine inhibits the production of interleukin-6 in fibroblast-like synoviocytes from adjuvant arthritis rats through PKC/MAPK/NF-κB-p65/CREB pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhifeng Wei Research Topics

Disease

17	Colitis 01/2024 - 12/2014
17	Experimental Arthritis 04/2023 - 08/2012
14	Arthritis (Polyarthritis) 10/2021 - 08/2012
9	Rheumatoid Arthritis 04/2023 - 08/2012
6	Inflammation (Inflammations) 01/2023 - 08/2012
6	Neoplasms (Cancer) 01/2022 - 06/2010
5	Hypoxia (Hypoxemia) 11/2023 - 04/2016
4	Ulcerative Colitis 01/2024 - 01/2018
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2022 - 01/2018
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2017
3	Urinary Bladder Neoplasms (Bladder Cancer) 05/2018 - 06/2010
3	Carcinoma (Carcinomatosis) 05/2018 - 08/2012
2	Fibrosis (Cirrhosis) 01/2023 - 01/2018
2	Hemorrhage 01/2023 - 01/2022
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2020
2	Colitis-Associated Neoplasms 01/2022 - 10/2020
2	Acute Lung Injury 07/2012 - 10/2011
1	Atrophy 05/2024
1	Primary Ovarian Insufficiency 05/2024
1	Renal Insufficiency (Renal Failure) 01/2023
1	Infections 01/2022
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2022
1	Pneumoperitoneum 01/2022
1	Incisional Hernia 01/2022
1	Peritonitis 01/2022
1	Asthma (Bronchial Asthma) 01/2021
1	Carcinogenesis 10/2020

Drug/Important Bio-Agent (IBA)

10	Dextran SulfateIBA 11/2023 - 12/2014
5	arctigeninIBA 01/2024 - 12/2014
5	morinIBA 01/2023 - 12/2015
5	norisoboldineIBA 01/2022 - 08/2012
5	tetrandrineIBA 01/2022 - 02/2016
5	TriterpenesIBA 01/2022 - 08/2012
5	AlkaloidsIBA 01/2022 - 08/2012
4	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2023 - 02/2016
4	Proteins (Proteins, Gene)FDA Link 04/2023 - 07/2014
4	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideIBA 01/2021 - 01/2018
4	madecassosideIBA 12/2020 - 08/2012
3	Dextrans (Dextran)FDA Link 01/2024 - 01/2021
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 10/2020
3	Butyrates (Butyrate)IBA 11/2022 - 11/2019
3	madecassic acidIBA 01/2022 - 01/2017
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2017
3	LipopolysaccharidesIBA 01/2021 - 10/2011
3	BerberineIBA 11/2019 - 01/2017
3	CollagenIBA 01/2018 - 08/2012
3	Interleukin-10 (Interleukin 10)IBA 01/2017 - 03/2015
3	CytokinesIBA 02/2016 - 03/2015
3	Interleukin-6 (Interleukin 6)IBA 12/2015 - 08/2012
3	ScopoletinIBA 07/2015 - 12/2012
2	bergeninIBA 05/2024 - 12/2019
2	SodiumIBA 01/2024 - 01/2023
2	NAD (NADH)IBA 01/2023 - 01/2018
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2018
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 01/2018
2	16S Ribosomal RNAIBA 12/2020 - 11/2019
2	alpinetinIBA 12/2019 - 01/2018
2	CurcuminIBA 01/2018 - 05/2015
2	MicroRNAs (MicroRNA)IBA 01/2018 - 08/2012
2	SaponinsIBA 03/2015 - 08/2012
1	AntioxidantsIBA 05/2024
1	triptolideIBA 05/2024
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2024
1	Glucose (Dextrose)FDA LinkGeneric 11/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2023
1	diallyl trisulfideIBA 06/2023
1	Cholinergic Agents (Cholinergics)IBA 04/2023
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 04/2023
1	AlbuminsIBA 01/2023
1	SirtuinsIBA 01/2023
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2023
1	NitrogenIBA 01/2023
1	CreatinineIBA 01/2023
1	Urea (Carbamide)FDA LinkGeneric 01/2023
1	Drinking WaterIBA 11/2022
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2022
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 01/2022
1	astragaloside AIBA 01/2022
1	Polysaccharides (Glycans)IBA 01/2022
1	alpha-hydroxyglutarateIBA 01/2022
1	EnzymesIBA 01/2022
1	IsoenzymesIBA 12/2021
1	epacadostatIBA 12/2021
1	Diclofenac (SR 38)FDA LinkGeneric 10/2021
1	Platelet-Derived Growth FactorIBA 10/2021
1	Mechanistic Target of Rapamycin Complex 2IBA 10/2021
1	OccludinIBA 01/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021
1	Coenzyme A (CoA)IBA 12/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2020
1	Butyric Acid (Butanoic Acid)IBA 12/2020

Therapy/Procedure

9	Oral Administration 11/2022 - 03/2015
3	Therapeutics 05/2015 - 08/2012
2	Peritoneal Dialysis 01/2023 - 01/2022
1	Renal Dialysis (Hemodialysis) 01/2023
1	Rectal Administration 11/2022
1	Intraperitoneal Injections 07/2022
1	Catheters 01/2022
1	Punctures 01/2022
1	Immunotherapy 12/2021